Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1016/j.ejphar.2012.02.043 http://repositorio.unifesp.br/handle/11600/34892 |
Resumo: | This study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved. |
id |
UFSP_236e49da24a77b039e4836348239a53d |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/34892 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in miceAntiulcerogenic activityHecogeninSteroid saponinAgave sisalanaGastroprotection mechanism of actionThis study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved.Univ Fed Ceara, Dept Physiol & Pharmacol, BR-60431270 Fortaleza, Ceara, BrazilUniv Fed Ceara, Dept Pharm, BR-60431270 Fortaleza, Ceara, BrazilUniv Fed Paraiba, Dept Pharmaceut Sci, BR-58100000 Joao Pessoa, Paraiba, BrazilUniv Fed Ceara, Dept Morphol, BR-60431270 Fortaleza, Ceara, BrazilUniversidade Federal de São Paulo, Dept Pharmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Pharmacol, BR-04044020 São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Elsevier B.V.Univ Fed CearaUniv Fed ParaibaUniversidade Federal de São Paulo (UNIFESP)Cerqueira, Gilberto SantosSantos e Silva, Gabriela dosVasconcelos, Emiliano RiosFragoso de Freitas, Ana PaulaMoura, Brinell ArcanjoMacedo, Danielle SilveiraSouto, Augusto LopesBarbosa Filho, Jose MariaAlmeida Leal, Luzia Kalyne deCastro Brito, Gerly Anne deSouccar, Caden [UNIFESP]Barros Viana, Glauce Socorro de2016-01-24T14:27:14Z2016-01-24T14:27:14Z2012-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion260-269application/pdfhttp://dx.doi.org/10.1016/j.ejphar.2012.02.043European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012.10.1016/j.ejphar.2012.02.043WOS000303436200036.pdf0014-2999http://repositorio.unifesp.br/handle/11600/34892WOS:000303436200036engEuropean Journal of Pharmacologyinfo:eu-repo/semantics/openAccesshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-08T12:12:24Zoai:repositorio.unifesp.br/:11600/34892Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-08T12:12:24Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
title |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
spellingShingle |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice Cerqueira, Gilberto Santos Antiulcerogenic activity Hecogenin Steroid saponin Agave sisalana Gastroprotection mechanism of action |
title_short |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
title_full |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
title_fullStr |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
title_full_unstemmed |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
title_sort |
Effects of hecogenin and its possible mechanism of action on experimental models of gastric ulcer in mice |
author |
Cerqueira, Gilberto Santos |
author_facet |
Cerqueira, Gilberto Santos Santos e Silva, Gabriela dos Vasconcelos, Emiliano Rios Fragoso de Freitas, Ana Paula Moura, Brinell Arcanjo Macedo, Danielle Silveira Souto, Augusto Lopes Barbosa Filho, Jose Maria Almeida Leal, Luzia Kalyne de Castro Brito, Gerly Anne de Souccar, Caden [UNIFESP] Barros Viana, Glauce Socorro de |
author_role |
author |
author2 |
Santos e Silva, Gabriela dos Vasconcelos, Emiliano Rios Fragoso de Freitas, Ana Paula Moura, Brinell Arcanjo Macedo, Danielle Silveira Souto, Augusto Lopes Barbosa Filho, Jose Maria Almeida Leal, Luzia Kalyne de Castro Brito, Gerly Anne de Souccar, Caden [UNIFESP] Barros Viana, Glauce Socorro de |
author2_role |
author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Univ Fed Ceara Univ Fed Paraiba Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Cerqueira, Gilberto Santos Santos e Silva, Gabriela dos Vasconcelos, Emiliano Rios Fragoso de Freitas, Ana Paula Moura, Brinell Arcanjo Macedo, Danielle Silveira Souto, Augusto Lopes Barbosa Filho, Jose Maria Almeida Leal, Luzia Kalyne de Castro Brito, Gerly Anne de Souccar, Caden [UNIFESP] Barros Viana, Glauce Socorro de |
dc.subject.por.fl_str_mv |
Antiulcerogenic activity Hecogenin Steroid saponin Agave sisalana Gastroprotection mechanism of action |
topic |
Antiulcerogenic activity Hecogenin Steroid saponin Agave sisalana Gastroprotection mechanism of action |
description |
This study investigates the gastroprotective effects of hecogenin, a steroid saponin isolated from Agave sisalana, on experimental models of gastric ulcer. Male Swiss mice were used in the models of ethanol-and indometacin-induced gastric ulcer. To clarify the hecogenin mechanism of action, the roles of nitric oxide (NO), sulfhydryls (GSH), K-ATP(+) channels and prostaglandins were also investigated, and measurements of lipid peroxidation (TBARS assay) and nitrite levels in the stomach of hecogenin-treated and untreated animals were performed. Furthermore, the effects of hecogenin on myeloperoxidase (MPO) release from human neutrophils were assessed in vitro. Our results showed that hecogenin (3.1, 7.5, 15, 30, 60 and 90 mg/kg, p.o.) acutely administered, before ethanol or indomethacin, exhibited a potent gastroprotective effect. Although the pretreatments with L-NAME, an iNOS inhibitor, and capsazepine, a TRPV1 receptor agonist, were not able to reverse the hecogenin effect, this was reversed by glibenclamide, a K-ATP(+) blocker, and indomethacin in the model of ethanol-induced gastric lesions. the hecogenin pretreatment normalized GSH levels and significantly reduced lipid peroxidation and nitrite levels in the stomach, as evaluated by the ethanol-induced gastric lesion model. the drug alone increased COX-2 expression and this effect was further enhanced in the presence of ethanol. It also decreased MPO release and significantly protected the gastric mucosa. in conclusion, we showed that hecogenin presents a significant gastroprotective effect that seems to be mediated by K-ATP(+) channels opening and the COX-2/PG pathway. in addition, its antioxidant and anti-inflammatory properties may play a role in the gastroprotective drug effect. (C) 2012 Elsevier B. V. All rights reserved. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-05-15 2016-01-24T14:27:14Z 2016-01-24T14:27:14Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ejphar.2012.02.043 European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012. 10.1016/j.ejphar.2012.02.043 WOS000303436200036.pdf 0014-2999 http://repositorio.unifesp.br/handle/11600/34892 WOS:000303436200036 |
url |
http://dx.doi.org/10.1016/j.ejphar.2012.02.043 http://repositorio.unifesp.br/handle/11600/34892 |
identifier_str_mv |
European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 683, n. 1-3, p. 260-269, 2012. 10.1016/j.ejphar.2012.02.043 WOS000303436200036.pdf 0014-2999 WOS:000303436200036 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
European Journal of Pharmacology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy |
dc.format.none.fl_str_mv |
260-269 application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier B.V. |
publisher.none.fl_str_mv |
Elsevier B.V. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268336053157888 |